Harnessing RNA viral variability to end RNA viral pandemics
- Funded by National Health and Medical Research Council (NHMRC)
- Total publications:0 publications
Grant number: GA352231
Grant search
Key facts
Disease
COVID-19Start & end year
20242028Known Financial Commitments (USD)
$1,369,268.29Funder
National Health and Medical Research Council (NHMRC)Principal Investigator
N/A
Research Location
AustraliaLead Research Institution
University of New South WalesResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Immunity
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
Although the viruses that cause HIV and COVID-19 are very different in terms of the way they spread and their disease courses, both pose challenges to their prevention and treatment because of their high ability to evolve new strains that are resistant to therapy and to vaccination. This project will explore next generation treatment and prevention pathways for both viruses which will be based on sophisticated understanding of the interactions between these viruses and the immune system.